|
FAM192A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.17680334763304E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33980004868306E-09 |
| Normal-vs-Stage2 |
5.338000E-03 |
| Normal-vs-Stage3 |
9.96336346759108E-12 |
| Normal-vs-Stage4 |
3.2660996129863E-10 |
| Stage1-vs-Stage2 |
1.249590E-01 |
| Stage1-vs-Stage3 |
4.841600E-03 |
| Stage1-vs-Stage4 |
5.893600E-02 |
| Stage2-vs-Stage3 |
1.519250E-03 |
| Stage2-vs-Stage4 |
7.500100E-03 |
| Stage3-vs-Stage4 |
7.351200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.41270337042465E-11 |
| Normal-vs-AfricanAmerican |
1.920480E-03 |
| Normal-vs-Asian |
1.57340999999978E-05 |
| Caucasian-vs-AfricanAmerican |
2.800000E-01 |
| Caucasian-vs-Asian |
3.031400E-01 |
| AfricanAmerican-vs-Asian |
7.705200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.09379999899429E-08 |
| Normal-vs-Female |
3.99680288865056E-11 |
| Male-vs-Female |
8.749400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.76279999486439E-08 |
| Normal-vs-Age(41-60Yrs) |
1.11319997664339E-09 |
| Normal-vs-Age(61-80Yrs) |
3.05180000159666E-08 |
| Normal-vs-Age(81-100Yrs) |
7.71970000146283E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.796000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.830600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.697100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.258600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.917200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.016100E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.77617000000074E-05 |
| Classical-VS-Follicular |
8.409600E-02 |
| Classical-VS-Other |
8.817200E-01 |
| Classical-VS-Normal |
1.69450009579464E-10 |
| Tall-VS-Follicular |
1.38900000001829E-06 |
| Tall-VS-Other |
5.876400E-02 |
| Tall-VS-Normal |
1.44995127016045E-13 |
| Follicular-VS-Other |
5.050400E-01 |
| Follicular-VS-Normal |
4.245100E-04 |
| Other-VS-Normal |
1.191910E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.02089999681954E-08 |
| Normal-vs-N1 |
6.48709974626627E-10 |
| N0-vs-N1 |
7.428500E-02 |
|
|
